---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-127644"
form_type: "8-K"
ticker: "CRBP"
cik: "0001595097"
company_name: "Corbus Pharmaceuticals Holdings, Inc."
filed_at: "2024-11-15T23:59:59+00:00"
generated_at: "2026-05-29T23:46:44.157517+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Board member Anne Altmeyer adopts 10b5-1 plan to sell up to 2,452 shares of CRBP common stock

## Summary
- Anne Altmeyer, Ph.D., board member, adopted Rule 10b5-1 plan on Nov 14, 2024.
- Plan allows sale of up to 2,452 shares of common stock.
- Sales may begin on February 13, 2025; plan terminates December 31, 2025.
- Plan is intended to satisfy affirmative defense under Rule 10b5-1(c).

## SEC filing metadata
- accession: 0000950170-24-127644
- form_type: 8-K
- ticker: CRBP
- cik: 0001595097
- company_name: Corbus Pharmaceuticals Holdings, Inc.
- filed_at: 2024-11-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1595097/000095017024127644/0000950170-24-127644-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1595097/000095017024127644/crbp-20241115.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-127644
- JSON: https://secwatch.observer/filing/0000950170-24-127644.json
- Plain text: https://secwatch.observer/filing/0000950170-24-127644.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.